Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
1993 • 2,906 citations
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
1993 • 1,941 citations
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
1994 • 1,140 citations
Clinical Features and Natural History of von Hippel-Lindau Disease
1990 • 916 citations
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
1994 • 646 citations
Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours
1994 • 531 citations
Identification of intragenic mutations in the Von Hippel — Lindau disease tumour suppressor gene andcorrelation with disease phenotype
1994 • 386 citations
A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
1995 • 253 citations
Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect
1995 • 177 citations
A Practical Guide to Human Cancer Genetics
2006 • 87 citations
10 Multiple endocrine neoplasia
1988 • 54 citations
Genetic linkage between Von Hippel—Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus
1993 • 52 citations
A Practical Guide to Human Cancer Genetics
1994 • 24 citations
A polymorphic dinucleotide repeat at the ZNF22 locus.
1993 • 15 citations
Familial risk for neuroendocrine tumors.
1993 • 14 citations
A polymorphic dinucleotide repeat at the D10S141 locus
1993 • 9 citations